Exact Sciences (EXAS) Cash from Investing Activities (2016 - 2025)
Exact Sciences (EXAS) has disclosed Cash from Investing Activities for 16 consecutive years, with $91.1 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities rose 317.61% to $91.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $195.1 million through Dec 2025, up 144.13% year-over-year, with the annual reading at $195.1 million for FY2025, 144.13% up from the prior year.
- Cash from Investing Activities for Q4 2025 was $91.1 million at Exact Sciences, up from -$86.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $224.9 million in Q2 2025, with the low at -$793.8 million in Q2 2021.
- Average Cash from Investing Activities over 5 years is -$60.3 million, with a median of -$38.2 million recorded in 2024.
- The sharpest move saw Cash from Investing Activities plummeted 12341.49% in 2021, then soared 317.61% in 2025.
- Over 5 years, Cash from Investing Activities stood at $78.4 million in 2021, then tumbled by 174.15% to -$58.2 million in 2022, then decreased by 14.8% to -$66.8 million in 2023, then skyrocketed by 37.29% to -$41.9 million in 2024, then soared by 317.61% to $91.1 million in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at $91.1 million, -$86.5 million, and $224.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.